Literature DB >> 21858563

[Allergen-specific immunotherapy in pet allergy - an update].

U Raap1, M Wagenmann, O Pfaar.   

Abstract

Animal dander is a common cause of allergic rhinitis and allergic asthma in patients. In this regard, cats and dogs represent major causes of allergy to animal dander. In first line, the therapeutic options include the elimination of the pet from the patient's home as a (secondary) preventive step. However, avoidance of temporary contacts or indirect exposure to cat dander is often difficult, since cat-allergens are widely distributed even in non-cat-keeping households. In general, conventional pharmacologic therapy does not thoroughly prevent allergic symptoms. Therefore, allergen-specific immunotherapy (SIT) represents an important therapeutic option. This article highlights the current standards and further developments of SIT for cat-allergic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858563     DOI: 10.1007/s00105-011-2159-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

1.  Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy.

Authors:  Hans Grönlund; Susanne Vrtala; Ursula Wiedermann; Gerhard Dekan; Dietrich Kraft; Rudolf Valenta; Marianne Van Hage-Hamsten
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Safety and efficacy of oral immunotherapy with standardized cat extract.

Authors:  J Oppenheimer; J G Areson; H S Nelson
Journal:  J Allergy Clin Immunol       Date:  1994-01       Impact factor: 10.793

3.  Immunotherapy with cat- and dog-dander extracts. IV. Effects of 2 years of treatment.

Authors:  G Lilja; B Sundin; V Graff-Lonnevig; G Hedlin; H Heilborn; K Norrlind; K O Pegelow; H Løwenstein
Journal:  J Allergy Clin Immunol       Date:  1989-01       Impact factor: 10.793

4.  Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: II--Morphometric assessment.

Authors:  C Charpin; T M Zielonka; D Charpin; J L Ansaldi; C Allasia; D Vervloet
Journal:  Clin Exp Allergy       Date:  1994-12       Impact factor: 5.018

5.  [Sublingual immunotherapy with cat epithelial extract. Personal experience].

Authors:  A Sánchez Palacios; F Schamann; J A García
Journal:  Allergol Immunopathol (Madr)       Date:  2001 Mar-Apr       Impact factor: 1.667

6.  Treatment of cat allergy with T-cell reactive peptides.

Authors:  P S Norman; J L Ohman; A A Long; P S Creticos; M A Gefter; Z Shaked; R A Wood; P A Eggleston; K B Hafner; P Rao; L M Lichtenstein; N H Jones; C F Nicodemus
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

7.  A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.

Authors:  Penelope A Ewbank; Jacquelyn Murray; Karrie Sanders; Douglas Curran-Everett; Stephen Dreskin; Harold S Nelson
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

8.  A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract.

Authors:  H S Nelson; J Oppenheimer; G A Vatsia; A Buchmeier
Journal:  J Allergy Clin Immunol       Date:  1993-08       Impact factor: 10.793

9.  Ubiquitous presence of cat allergen in cat-free buildings: probable dispersal from human clothing.

Authors:  R N Enberg; S M Shamie; J McCullough; D R Ownby
Journal:  Ann Allergy       Date:  1993-06

Review 10.  Recombinant allergens: what does the future hold?

Authors:  Rudolf Valenta; Katarzyna Niespodziana; Margit Focke-Tejkl; Katharina Marth; Hans Huber; Angela Neubauer; Verena Niederberger
Journal:  J Allergy Clin Immunol       Date:  2011-04       Impact factor: 10.793

View more
  1 in total

Review 1.  Allergen Immunotherapy: Past, Present, and Future.

Authors:  Marek Jutel; Anna Kosowska; Sylwia Smolinska
Journal:  Allergy Asthma Immunol Res       Date:  2016-05       Impact factor: 5.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.